IMC has served healthcare organizations, public health institutions, and pharmaceutical companies to manage their vast amounts of clinical data in a better way. Their industry experts provide solutions for timely data standardization and efficient medical records management and help promote efficacy through accelerated drug discovery and patient diagnostics. IMC has helped a number of customers in federal government and commercial space through software product development,testing and full lifecycle support of web applications. IMC Patient Safety Reporting applications enable field medical professionals to observe patients and clinical trial participants in real-time for Serious Adverse Events (SAEs). IMC has also developed the Serious Adverse Event Tracking and Reporting System(SAETRS)to meet regulatory requirements for detecting and reporting SAEs that can occur during clinical research. IMC Data Visualization and Analysis applications allow research institutions and pharmaceutical companies to draw insights and correlations from vast quantities of patient clinical and genomic data to support cases for drug discovery and drug device validation.
Combining leading technologies with IMC service offerings, clients can identify, consolidate, standardize, and modernize their infrastructures
IMC has been in business for almost 35 years. “We have always had growth in almost every one of those years and anticipate keeping the successful formula in the future,” asserts Shenoy. IMC plans to continue focusing on content management applications, which is growing three to four times the rate of other kinds of data. “Most of our customers are seeing the need for content analytics and mining for better business outcomes,” he concludes.